Haemonetics Corp. (HAE)
Haemonetics Market Cap : 2.738B for March 19, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Abbott Laboratories | 186.24B |
| Boston Scientific Corp. | 103.71B |
| Edwards Lifesciences Corp. | 47.90B |
| QuidelOrtho Corp. | 1.128B |
| Stryker Corp. | 130.03B |
Market Cap Related Metrics
| PE Ratio | 16.19 |
| PS Ratio | 2.150 |
| PEG Ratio | 0.3744 |
| Price to Book Value | 3.004 |
| Price to Free Cash Flow | 9.202 |
| Price | 58.91 |
| Earnings Yield | 6.18% |
| PEGY Ratio | 0.3744 |
| Operating PE Ratio | 11.64 |
| Normalized PE Ratio | 16.15 |